Explore the latest in psoriasis, including advances in understanding the epidemiology, genetics, and management of the disease.
This case report describes the occurrence of acrodermatitis continua of Hallopeau being mistaken for recurrent cellulitis.
This systematic review summarizes the evidence on the efficacy of the most studied complementary and alternative medicine therapies for treatment of plaque psoriasis and discusses those treatments with the most robust available evidence.
This systematic review and meta-analysis of 9 studies comprising more than 7 million patients examines the association between psoriasis and inflammatory bowel disease.
This systematic review evaluates the main characteristics of the studies of psoriasis and sexual dysfunction (SD) or erectile dysfunction (ED), including level of evidence, tools used to assess SD or ED, and prevalence and incidence of SD or ED.
This randomized clinical trial examines whether an online, collaborative connected-health model results in equivalent clinical improvements compared with in-person care among US adults with psoriasis.
This study assesses the association between aortic vascular inflammation by fludeoxyglucose F 18 positron emission tomography/computed tomography and coronary artery disease indices by coronary computed tomography angiography.
This Delphi survey of patients, health care professionals, and other stakeholders identifies a core set of 6 domains that should be measured in all clinical trials for psoriasis therapies.
This case report describes a 43-year-old man with psoriasis and mucous membrane pemphigoid who received treatment with baricitinib.
This cohort study uses a self-completed questionnaire by respondents in the French NutriNet-Santé study to evaluate the association between a Mediterranean anti-inflammatory dietary profile and the severity of psoriasis.
This case report describes the use of topical crisaborole to treat previously treatment-refractory palmoplantar psoriasis
This systematic review presents evidence-based dietary recommendations for adults with psoriasis or psoriatic arthritis from the Medical Board of the National Psoriasis Foundation.
This secondary analysis of 2 randomized clinical trials evaluates the effect of guselkumab vs adalimumab or placebo on psoriasis in specific difficult-to-treat body regions.
This observational study examines whether drug discontinuation, effectiveness, and rates of serious adverse events differ in patients with psoriasis being treated with biologics who have been categorized as eligible or ineligible for clinical trials.
This case report describes a 71-year-old man with psoriatic arthritis and stage IV cutaneous melanoma who presented with iritis in the right eye.
This cohort study examines the risk ocomorbidities in children with and without psoriasis, after accounting for obesity.
This randomized clinical trial evaluates the safety and efficacy of guselkumab compared with placebo for the treatment of palmoplantar pustulosis.
This cohort study examines estimated herpes zoster incidence rates among systemically treated patients with psoriasis in a community-based health care delivery setting.
This Medical Letter review summarizes the mechanism of action and adverse effects of guselkumab, an interleukin-23 blocker, for treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic or phototherapy.
This cohort study investigates whether patients with psoriasis have an elevated risk of alcohol-related mortality.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: